bpc-157 side effects reported Regeneration or Risk? A Narrative Review of for Musculoskeletal Healing The Hidden Risks of BPC‑157:

BV and melittin influence several intracellular pathways, and their blockage triggers apoptosis., melittin inhibits the PI3K/Akt/mTOR pathway in breast cancer cells (Pandey et al., 2023b), or liver cancer cells (Lv et al., 2023)

216 In addition, PKC also facilitated occludin and ZO-1 assembly via the phosphorylation of Thr residues at the C-terminus of occludin

doi: 10.1016/j.jams.2017.08.004

We speculate that the BPC157-FBXO22 interaction via P3 delays enzymatic degradationpeptide catabolism typically initiates with endopeptidases, followed by stepwise proteolysis into amino acids

Direct answer: Yes, current data suggests it remains safe with proper monitoring

Therefore, all the scientific information on its effects is only available from animal and in vitro studies